ResMed (RMD) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $221.97 --0%
EPS Growth %: +5.5%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: +5.5%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, $0.01 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $406.29 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
